We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

BioVendor Group

BioVendor Group is an international group of biotechnology companies (BioVendor LM, BioVendor R&D, TestLine, ViennaLa... read more Featured Products: More products

Download Mobile App




Fructose Ingestion Stimulates Hormone Leading to Fructose Tolerance Test

By LabMedica International staff writers
Posted on 04 Nov 2014
Print article
Biovendor\'s enzyme-linked immunosorbent assay kit for measuring protein markers
Enzyme-linked immunosorbent assay kit for measuring protein markers (Photo courtesy of BIOVENDOR Group)
The determination of the body's metabolic response to fructose has been very difficult, and consequently, there is no fructose tolerance test to warn of impaired or altered fructose metabolism.

Fibroblast growth factor 21 (FGF21) is a recently discovered hormone produced primarily by key metabolic tissues including the liver and adipose tissue which has pleiotropic actions on glucose and lipid homeostasis and theoretically fructose ingestion might acutely stimulate production of FGF21.

Endocrinologists at the Beth Israel Deaconess Medical Center (Boston, MA, USA) recruited 10 lean, healthy study subjects and 11 patients with metabolic syndrome. They first tested the effect of glucose on FGF21 by giving volunteers a drink of 75 grams of glucose and measuring serum levels of glucose, cholesterol, and triglyceride levels which were analyzed over the course of five hours. Insulin samples were measured by radioimmunoassay (Millipore; Billerica, MA, USA). The study subjects were later given 75 grams of fructose or a combination of 37.5 grams of fructose and 37.5 grams of glucose dissolved in 225 mL water.

Serum FGF21 levels were measured using a commercially available enzyme-linked immunosorbent assay (BioVendor USA; Candler, NC, USA) from blood collected in aprotinin-pretreated tubes and were stored at -80 °C until use. Metabolic syndrome subjects had lower high-density lipoprotein (HDL) cholesterol, higher systolic blood pressure, and higher fasting and two-hour glycemia during an oral glucose tolerance test. However, after ingesting 75 grams of fructose, FGF21 levels dramatically increased by an average of 400% within only two hours.

Eleftheria Maratos-Flier, MD, a professor of Medicine and senior author of the study said, “This study tells us that fructose actively regulates FGF21 in humans. The hormone-like response of FGF21 to fructose ingestion suggests that FGF21 might play an unanticipated role in regulating fructose metabolism. We were totally surprised by this dramatic effect because, to date, there has been no way of assessing the body's acute metabolic response to fructose ingestion. We haven't had a simple quick test like we have for glucose.” The study was published on October 8, 2014, in the journal Molecular Metabolism.

Related Links:

Beth Israel Deaconess Medical Center
Millipore  
BioVendor USA  


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Plasma Control
Plasma Control Level 1
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Pathology

view channel
Image: Comparison of traditional histopathology imaging vs. PARS raw data (Photo courtesy of University of Waterloo)

AI-Powered Digital Imaging System to Revolutionize Cancer Diagnosis

The process of biopsy is important for confirming the presence of cancer. In the conventional histopathology technique, tissue is excised, sliced, stained, mounted on slides, and examined under a microscope... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.